Global Intravenous Infusion Pump Market Report Size, Trends & Growth Opportunity, By Infusion Pumps (Implantable Infusion Pumps, Patient Controlled Analgesics, Ambulatory Infusion Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, and Volumetric Infusion Pumps) By Disease Indication Type (Hematology, Pediatrics/Neonatology, Analgesia/Pain Management, Gastroenterology, Diabetics, Chemotherapy, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East) And Forecast Till 2027.
Market Overview
Global Intravenous Infusion Pump Market was valued at USD 5,154.30 in 2022 which is expected to reach USD $8,147.20 billion by 2027 at a CAGR 7.93%.
Intravenous infusion pump is a medical device which is used to deliver fluids such as medications, and nutrients directly into a circulatory system by using intravenous route. They are widely used in transferring medications in controlled manner. Rise in geriatric population and prevalence of chronic diseases will boost the global intravenous infusion pump market.
Market Drivers
Increase in demand for ambulatory infusion pumps in home care setting which is expected to drive the global intravenous infusion pump market growth. Furthermore, rise in incidences of chronic diseases along with rapid growth of the geriatric population which is expected to propel the global intravenous infusion pump market growth. Moreover, growing number of surgical procedures will have the positive impact on global intravenous infusion pump market growth. Also, rise in approval activities by regulatory authority will fuel the growth of global intravenous infusion pump industry. For instance, May 2018, Baxter had received US FDA clearance for Spectrum IQ infusion system with Dose IQ safety software.
Market Restraints
However, stringent rules and regulations for approval of new product is the restraining factor which is expected to hamper the global intravenous infusion pump market.
Market Segmentation
Global Intravenous Infusion Pump Market is segmented into product such as Infusion pumps (Implantable Infusion Pumps, Patient Controlled Analgesics, Ambulatory Infusion Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, and Volumetric Infusion Pumps). Further, Global Intravenous Infusion Pump Market is segmented into disease indication such as Hematology, Pediatrics/Neonatology, Analgesia/Pain Management, Gastroenterology, Diabetics, Chemotherapy, and Others.
Regional Analysis
Global Intravenous Infusion Pump Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. With a 49.6% market share in 2022, North America dominated the market for intravenous infusion pumps, and this trend is anticipated to last the entire forecast period. The development of the intravenous pumps sector in this area was aided by the rising prevalence of chronic diseases, rising surgical operations, well-developed and expanding R&D, and rising use of cutting-edge infusion pump technology. Because of its extensive healthcare infrastructure, high medical R&D spending, and high disease prevalence, the U.S. owned the biggest market share of the North American intravenous infusion industry. Due to their lifestyle and stressful work environment, Americans also have a significant prevalence of diabetes.
Market Key Players
Various key players are discussed in this report such as Johnson & Johnson,  F. Hoffmann-la Roche Ltd, Terumo Corporation, Smiths Group plc, Medtronic plc,  Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Pfizer Inc., Baxter International, Inc., Dickinson and Company, and Becton, Dickinson & Company.
Market Taxonomy
By Product
•        Infusion pumps
o Implantable Infusion Pumps
o Patient Controlled Analgesics
o Ambulatory Infusion Pumps
o Enteral Infusion Pumps
o Syringe Infusion Pumps
o Insulin Infusion Pumps
o Volumetric Infusion Pumps
By Diseases Indication
•        Hematology
•        Pediatrics/Neonatology
•        Analgesia/Pain Management
•        Gastroenterology
•        Diabetics
•        Chemotherapy
•        Others
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa
 

Global Intravenous Infusion Pump Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Intravenous Infusion Pump Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Intravenous Infusion Pump Market, By Product
5.1 Y-o-Y Growth Comparison, By Product 
5.2 Global Intravenous Infusion Pump Market Share Analysis, By Product 
5.3 Global Intravenous Infusion Pump Market Size and Forecast, By Product
5.3.1 Infusion Pumps
        5.3.1.1 Implantable Infusion Pump
        5.3.1.2 Patient Controlled Analgesics
        5.3.1.4 Ambulatory Infusion Pumps
        5.3.1.5 Enteral Infusion Pumps
        5.3.1.6 Syringe Infusion Pump
        5.3.1.7 Insullin Infusion Pump
        5.3.1.8 Volumetric Infusion Pump
6 Global Intravenous Infusion Pump Market, By Disease Indication
6.1 Y-o-Y Growth Comparison, By Disease Indication
6.2 Global Intravenous Infusion Pump Market Share Analysis, By Disease Indication
6.3 Global Intravenous Infusion Pump Market Size and Forecast, By Disease Indication
6.3.1 Haematology
6.3.2 Paediatric/Neonatology
6.3.3 Analgesia/Pain Management
6.3.4 Gastroenterology
6.3.5 Diabetics
6.3.6 Chemotherapy
6.3.7 Others
7 Global Intravenous Infusion Pump Market, By Region
7.1 Global Intravenous Infusion Pump Market Share Analysis, By Region
7.2 Global Intravenous Infusion Pump Market Share Analysis, By Region
7.3 Global Intravenous Infusion Pump Market Size and Forecast, By Region
8 North America Intravenous Infusion Pump Market Analysis and Forecast (2022-2027)
8.1 Introduction
8.2 North America Intravenous Infusion Pump Market Share Analysis, By Product
8.3 North America Intravenous Infusion Pump Market Size and Forecast, By Disease Indication
8.4 North America Intravenous Infusion Pump Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9 Europe Intravenous Infusion Pump Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 Europe Intravenous Infusion Pump Market Share Analysis, By Product 
9.3 Europe Intravenous Infusion Pump Market Size and Forecast, By Disease Indication 
9.4 Europe Intravenous Infusion Pump Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Intravenous Infusion Pump Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Asia Pacific Intravenous Infusion Pump Market Share Analysis, By Product 
10.3 Asia Pacific Intravenous Infusion Pump Market Size and Forecast, By Disease Indication 
10.4 Asia Pacific Intravenous Infusion Pump Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Intravenous Infusion Pump Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Latin America Intravenous Infusion Pump Market Share Analysis, By Product 
11.3 Latin America Intravenous Infusion Pump Market Size and Forecast, By Disease Indication 
11.4 Latin America Intravenous Infusion Pump Market Size and Forecast, By Country
12 Middle East Intravenous Infusion Pump Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Middle East Intravenous Infusion Pump Market Share Analysis, By Product 
12.3 Middle East Intravenous Infusion Pump Market Size and Forecast, By Disease Indication 
12.4 Middle East Intravenous Infusion Pump Market Size and Forecast, By Country
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Johnson & Johnson
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Hoffmann-la Roche Ltd
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Terumo Corporation
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Smiths Group plc
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Medtronic plc
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Fresenius SE & CO. KGaA
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Braun Melsungen AG,
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Pfizer Inc
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Baxter International, Inc,
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Dickinson and Company
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.11 Becton
14.11.1 Overview
14.11.2 Offerings
14.11.3 Key Financials
14.11.4 Business Segment & Geographic Overview
14.11.5 Key Market Developments
14.11.6 Key Strategies